Impact Biomedical annual gross margin
2025
Impact Biomedical Gross Margin Growth & History (IBO)
Impact Biomedical's gross margin was −1,225.00% for fiscal 2025.
View full Impact Biomedical company overviewImpact Biomedical annual gross margin history
| Fiscal year | Period ended | Gross margin | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | −1,225.00% | — |
Impact Biomedical quarterly gross margin
Q2.25
Q3.25
Q4.25
Q2.26
| Fiscal quarter | Period ended | Gross margin | Change (percentage points) |
|---|---|---|---|
| Q2 2026 | 2026-06-30 | 66.67% | −19.05 pp |
| Q4 2025 | 2025-12-31 | −5,928.57% | — |
| Q3 2025 | 2025-09-30 | 94.44% | — |
| Q2 2025 | 2025-06-30 | 85.71% | — |
Impact Biomedical gross margin trends
The latest reported quarter, Q2 2026, shows 66.67%.
About the metric
What gross margin means
Gross margin measures the percentage of revenue remaining after the direct costs of producing goods or services. It helps show how efficiently a company turns sales into gross profit before operating expenses.
Calculation and source
How gross margin is calculated
TickerStat calculates gross margin as SEC-reported gross profit divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Impact Biomedical source filings ↗